Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease
Clinical trial NCT02177344 · COMPLETED
Trial details
- NCT number
- NCT02177344
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 1999-10-01
- Enrollment
- 646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.